Table 1.
CRC Screening Before and During COVID-19 Pandemic Among Adults Aged 50–75 Years, National Health Interview Survey 2019–2021
| Up-to-date screening, % (95% CI) |
Past-year CRC screening (CRC screening within 12 mo, % [95% CI]) |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Any tests |
Invasivea |
Noninvasivea |
Colonoscopy |
Sigmoidoscopy |
FIT |
FIT-DNAb |
CT |
|||||||||||
| 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | 2019 | 2021 | |
| All participants | 66.7 (65.7–67.7) | 70.9 (69.9–71.9) | 21.2 (20.4–22.0) | 24.0 (23.1–25.0) | 15.5 (14.7–16.2) | 13.8 (13.1–14.5) | 7.0 (6.4–7.5) | 12.8 (12.0–13.6) | 15.2 (14.4–15.9) | 13.5 (12.8–14.2) | 0.9 (0.7–1.1) | 1.1 (0.8–1.3) | 6.7 (6.1–7.2) | 10.1 (9.4–10.8) | 1.7 (1.4–2.0) | 2.3 (2.0–2.6) | 0.6 (0.4–0.7) | 1.1 (0.8–1.3) |
| Age groups | ||||||||||||||||||
| 50–54 years | 45.8 (43.4–48.2) | 51.5 (49.1–53.9) | 18.3 (16.5–20.0) | 22.1 (20.1–24.0) | 15.1 (13.4–16.8) | 13.2 (11.6–14.8) | 4.3 (3.3–5.2) | 10.6 (9.3–12.0) | 15.1 (13.4–16.7) | 12.8 (11.2–14.4) | 0.6 (0.3–0.9) | 0.8 (7.2–9.6) | 4.0 (3.0–4.9) | 8.4 (7.2–9.6) | 1.0 (0.5–1.5) | 1.9 (1.3–2.5) | 0.4 (0.1–0.7) | 0.9 (0.4–1.4) |
| 55–64 years | 67.9 (66.3–69.4) | 71.4 (69.9–73.0) | 19.6 (18.4–20.8) | 22.3 (21.0–23.6) | 14.4 (13.3–15.5) | 13.4 (12.4–14.5) | 6.2 (5.4–7.0) | 11.5 (10.4–12.6) | 14.0 (12.9–15.1) | 13.3 (12.2–14.3) | 0.9 (0.6–1.2) | 1.1 (0.7–1.5) | 6.0 (5.3–6.8) | 9.1 (8.1–10.1) | 1.5 (1.1–1.9) | 1.9 (1.5–2.3) | 0.4 (0.2–0.6) | 1.2 (0.8–1.6) |
| 65–75 years | 78.1 (76.7–79.4) | 81.4 (80.1–82.7) | 25.1 (23.7–26.5) | 27.2 (25.8–28.7) | 17.1 (15.9–18.4) | 14.7 (13.5–15.8) | 9.7 (8.7–10.6) | 15.6 (14.3–16.8) | 16.8 (15.6–18.0) | 14.2 (13.1–15.3) | 1.1 (0.8–1.4) | 1.2 (0.9–1.6) | 9.1 (8.2–10.1) | 12.4 (11.3–13.5) | 2.5 (1.9–3.0) | 3.1 (2.5–3.6) | 0.8 (0.6–1.1) | 1.0 (0.7–1.4) |
| Sex | ||||||||||||||||||
| Men | 64.9 (63.4–66.4) | 69.8 (68.4–71.3) | 20.7 (19.5–21.9) | 23.4 (22.1–24.7) | 15.6 (14.5–16.7) | 14.1 (13.0–15.1) | 6.2 (5.5–7.0) | 12.1 (11.1–13.2) | 15.2 (14.1–16.3) | 13.8 (12.7–14.8) | 0.9 (0.6–1.1) | 1.2 (0.8–1.6) | 6.0 (5.2–6.7) | 9.6 (8.7–10.5) | 1.5 (1.2–1.9) | 2.1 (1.7–2.5) | 0.5 (0.3–0.7) | 1.2 (0.8–1.5) |
| Women | 68.3 (67.0–69.6) | 71.9 (70.6–73.3) | 21.7 (20.6–22.8) | 24.6 (23.4–25.9) | 15.4 (14.4–16.4) | 13.6 (12.6–14.6) | 7.7 (6.9–8.4) | 13.4 (12.4–14.5) | 15.2 (14.2–16.1) | 13.3 (12.3–14.3) | 0.9 (0.7–1.2) | 0.9 (0.7–1.2) | 7.3 (6.5–8.0) | 10.6 (9.7–11.6) | 1.9 (1.4–2.3) | 2.6 (2.1–3.0) | 0.6 (0.4–0.9) | 1.0 (0.7–1.3) |
| Race | ||||||||||||||||||
| White | 70.1 (69.0–71.2) | 74.0 (72.9–75.0) | 20.5 (19.5–21.4) | 23.0 (21.9–24.0) | 15.0 (14.2–15.9) | 13.6 (12.8–14.4) | 6.5 (5.9–7.1) | 11.3 (10.5–12.1) | 14.9 (14.0–15.7) | 13.4 (12.5–14.2) | 0.8 (0.6–0.9) | 0.8 (0.6–1.0) | 6.2 (5.6–6.8) | 8.8 (8.0–9.5) | 1.8 (1.5–2.2) | 2.4 (2.0–2.8) | 0.4 (0.3–0.5) | 0.8 (0.6–1.0) |
| Hispanics | 52.0 (48.6–55.5) | 60.4 (57.0–63.8) | 20.0 (17.5–22.5) | 26.4 (23.6–29.3) | 13.0 (10.9–15.1) | 12.6 (10.6–14.6) | 8.4 (6.6–10.2) | 17.7 (15.0–20.3) | 12.7 (10.6–14.8) | 12.0 (10.0–14.0) | 0.9 (0.4–1.5) | 1.3 (0.6–2.0) | 8.0 (6.2–9.8) | 15.2 (12.8–17.6) | 1.0 (0.4–1.6) | 2.1 (1.2–2.9) | 1.0 (0.3–1.6) | 1.1 (0.6–1.7) |
| Black | 67.0 (64.1–69.9) | 70.2 (67.1–73.2) | 27.4 (24.8–30.0) | 28.2 (25.4–31.0) | 21.9 (19.4–24.5) | 17.1 (14.9–19.4) | 7.4 (5.8–9.1) | 15.2 (12.9–17.5) | 21.1 (18.6–23.7) | 16.7 (14.4–18.9) | 1.7 (1.0–2.4) | 2.1 (1.0–3.2) | 6.7 (5.1–8.2) | 11.7 (9.7–13.8) | 1.9 (0.8–3.0) | 2.4 (1.4–3.3) | 1.5 (0.8–2.2) | 2.2 (1.1–3.4) |
| Asian | 56.0 (50.4–61.7) | 59.6 (54.7–64.6) | 20.8 (17.0–24.7) | 21.4 (17.8–24.9) | 14.2 (10.6–17.8) | 11.1 (8.3–13.9) | 8.4 (5.9–10.8) | 13.2 (10.4–16.0) | 13.5 (10.0–17.0) | 10.8 (8.1–13.4) | 1.4 (0.2–2.5) | 1.2 (0.3–2.1) | 8.4 (5.9–10.8) | 11.2 (8.5–13.9) | 1.1 (0.1–2.1) | 1.6 (0.5–2.6) | 0.1 (0–0.4) | 0.8 (0.1–1.5) |
| Household income | ||||||||||||||||||
| <200% FPL | 55.0 (52.8–57.2) | 60.0 (57.9–62.1) | 20.8 (19.3–22.4) | 25.1 (23.1–27.0) | 14.4 (13.0–15.7) | 13.7 (12.2–15.1) | 8.1 (6.9–9.3) | 15.7 (14.0–17.4) | 14.0 (12.6–15.4) | 13.1 (11.7–14.6) | 1.0 (0.7–1.4) | 2.0 (1.4–2.7) | 7.8 (6.6–8.9) | 12.1 (10.6–13.7) | 2.1 (1.5–2.8) | 2.3 (1.7–2.9) | 0.6 (0.3–1.0) | 2.1 (1.3–2.8) |
| 200%–400% FPL | 65.1 (63.3–67.0) | 69.1 (67.3–71.0) | 20.6 (19.1–22.1) | 23.7 (22.1–25.3) | 14.9 (13.5–16.3) | 13.0 (11.6–14.3) | 7.0 (6.0–7.9) | 12.9 (11.6–14.2) | 14.6 (13.2–16.0) | 12.8 (11.4–14.1) | 1.2 (0.8–1.5) | 0.8 (0.5–1.2) | 6.6 (5.7–7.5) | 10.5 (9.3–11.7) | 1.8 (1.3–2.3) | 2.5 (1.9–3.1) | 0.5 (0.3–0.7) | 0.9 (0.6–1.3) |
| ≥400% FPL | 74.4 (73.1–75.8) | 77.3 (76.1–78.4) | 21.8 (20.6–23.1) | 23.7 (22.5–24.9) | 16.5 (15.4–17.6) | 14.4 (13.4–15.4) | 6.4 (5.6–7.1) | 11.3 (10.4–12.3) | 16.6 (15.1–17.4) | 14.1 (13.1–15.1) | 0.7 (0.5–0.9) | 0.7 (0.5–1.0) | 6.1 (5.3–6.8) | 8.9 (8.1–9.8) | 1.4 (1.0–1.8) | 2.2 (1.9–2.6) | 0.6 (0.3–0.8) | 0.7 (0.5–0.9) |
| Education | ||||||||||||||||||
| <High school | 50.8 (47.2–54.5) | 57.8 (54.3–61.3) | 20.1 (17.5–22.7) | 24.9 (21.6–28.1) | 13.2 (11.1–15.4) | 14.4 (11.9–16.8) | 8.6 (6.7–10.4) | 15.4 (12.6–18.2) | 12.8 10.7–14.9) |
13.8 (11.3–16.2) | 1.1 (0.5–1.6) | 2.5 (1.4–3.5) | 8.2 (6.4–10.0) | 12.9 (10.3–15.5) | 1.9 (1.0–2.8) | 1.6 (0.7–2.5) | 0.7 (0.1–1.3) | 1.7 (0.8–2.6) |
| High school | 63.0 (61.1–64.8) | 66.1 (64.1–68.0) | 20.6 (19.1–22.0) | 23.1 (21.4–24.9) | 15.7 (14.4–17.0) | 13.1 (11.7–14.4) | 6.2 (5.2–7.1) | 12.8 (11.4–14.2) | 15.4 (14.1–16.7) | 12.8 (11.4–14.1) | 0.9 (0.5–1.2) | 1.2 (0.7–1.8) | 5.9 (5.0–6.9) | 9.8 (8.5–11.0) | 1.7 (1.1–2.3) | 2.5 (1.9–3.1) | 0.6 (0.3–0.9) | 1.3 (0.8–1.8) |
| Associate | 69.2 (67.4–70.9) | 72.2 (70.4–74.0) | 21.8 (20.3–23.3) | 24.2 (22.6–25.9) | 15.6 (14.3–17.0) | 13.3 (12.0–14.7) | 7.3 (6.3–8.2) | 13.4 (12.1–14.7) | 15.4 (14.0–16.7) | 13.0 (11.7–14.3) | 1.1 (0.7–1.4) | 0.9 (0.5–1.2) | 6.8 (5.8–7.7) | 10.5 (9.3–11.7) | 1.7 (1.3–2.2) | 2.6 (2.0–3.2) | 0.6 (0.3–0.8) | 1.2 (0.8–1.6) |
| ≥College | 74.7 (73.1–76.3) | 77.3 (75.9–78.7) | 21.9 (20.5–23.3) | 24.4 (22.9–25.8) | 16.3 (15.0–17.5) | 14.6 (13.5–15.7) | 6.8 (5.9–7.6) | 11.6 (10.5–12.7) | 16.0 (14.8–17.2) | 14.4 (13.3–15.5) | 0.7 (0.5–1.0) | 0.7 (0.4–1.0) | 6.6 (5.7–7.4) | 9.4 (8.4–10.4) | 1.5 (1.1–2.0) | 2.1 (1.7–2.6) | 0.4 (0.2–0.6) | 0.6 (0.4–0.9) |
CI, confidence interval; COVID-19, coronavirus disease 2019; CRC, colorectal cancer; CT, computed tomography; FIT, fecal immunochemical test; FPL, federal poverty line.
a
Invasive studies include colonoscopy and flexible sigmoidoscopy. Noninvasive studies include FIT, FIT-DNA, and CT colonography.
b
Time since most recent FIT-DNA was not released for survey year 2019.5 For this analysis, respondents were considered to have past-year screening with FIT-DNA if their most recent FIT was part of FIT-DNA and received within 1 year.10 Respondents were considered to have up-to-date screening with FIT-DNA if their most recent FIT was part of FIT-DNA and received within 3 years.10